Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-034258
Filing Date
2021-08-26
Accepted
2021-08-26 16:32:16
Documents
2
Period of Report
2021-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1543
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4453
  Complete submission text file 0000899243-21-034258.txt   7396
Mailing Address 175 WATER STREET NEW YORK NY 10038
Business Address
Dachille Douglas A. (Reporting) CIK: 0001652908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 211212773

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations